Skip NavigationSkip to Content

Carminomycin I Is an Apoptosis Inducer That Targets the Golgi Complex in Clear Cell Renal Carcinoma Cells

  1. Author:
    Woldemichael, G. M.
    Turbyville, T. J.
    Linehan, W. M.
    McMahon, J. B.
  2. Author Address

    [Woldemichael, Girma M.] NCI, Mol Targets Lab, SAIC Frederick Inc, Frederick, MD 21702 USA. [Turbyville, Thomas J.] NCI, Opt Microscopy & Anal Lab, SAIC Frederick Inc, Frederick, MD 21702 USA. [Linehan, W. Marston] NCI, Urol Oncol Branch, Clin Res Ctr, Bethesda, MD 20892 USA. [McMahon, James B.] NCI, Mol Targets Lab, Ctr Canc Res, Frederick, MD 21702 USA.;Woldemichael, GM, NCI, Mol Targets Lab, SAIC Frederick Inc, 1053 Boyles St,Bldg 538,Room 131, Frederick, MD 21702 USA.;woldemichaelg@mail.nih.gov
    1. Year: 2011
    2. Date: Jan
  1. Journal: Cancer Research
    1. 71
    2. 1
    3. Pages: 134-142
  2. Type of Article: Article
  3. ISSN: 0008-5472
  1. Abstract:

    Clear cell renal cell carcinoma (CCRCC) evolves due to mutations in the Von Hippel-Lindau (VHL) tumor suppressor gene. Although the loss of VHL enables survival and proliferation of CCRCC cells, it is also expected to introduce vulnerabilities that may be exploited for therapeutics discovery. To this end, we developed a high-throughput screen to identify small molecules derived from plants, microorganisms, and marine organisms to which CCRCC cells are sensitive. Screening over 8,000 compounds using this approach, we report here the identification of the microbially derived compound carminomycin I (CA) as an effective inhibitor of VHL-defective (VHL-/-) CCRCC cell proliferation. CA also induced apoptosis in CCRCC cells by a mechanism independent of p53 or hypoxia-inducible factor 2. We found that P-glycoprotein (P-gp) sequestered CA within the Golgi complex. Interestingly, Golgi sequestration was critical for the antiproliferative effects of CA and P-gp inhibitors abrogated this activity. Furthermore, CA induced cleavage of the Golgi protein p115 and the translocation of its C-terminal fragment to the nucleus. Finally, examination of the activity of the VHL-interacting Golgi protein, endoplasmic reticulum-Golgi intermediate compartment, ERGIC-53 showed that VHL could mediate protection from CA in CCRCC cells. Our natural product-based screening approach has revealed the P-gp-mediated localization of anticancer compounds within the Golgi in CCRCC cells as a potential strategy of targeting VHL-deficient CCRCC cells. Cancer Res; 71(1); 134-42. (C) 2011 AACR.

    See More

External Sources

  1. DOI: 10.1158/0008-5472.can-10-0757
  2. WOS: 000285826800016

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel